EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens

Kate Reddington, Nina Tuite, Elizabeth Minogue, Thomas Barry

Biomolecular Detection and Quantification · 2014

DOI: 10.1016/j.bdq.2014.07.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecular Detection and Quantification, 2014. Verfasst von Kate Reddington und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nucleic Acid Diagnostics Research Laboratory (NADRL), Microbiology, School of Natural Sciences, National University of Ireland, Galway, Ireland. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science Foundation Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastroenteritis is caused by a wide range of viral, bacterial and parasitic pathogens and causes millions of deaths worldwide each year, particularly in infant populations in developing countries. Traditional microbiological culture and immunological based tests are time consuming, laborious and often lack diagnostic specificity and sensitivity. As a result patients can receive suboptimal and/or inappropriate antimicrobial treatment. In recent years, rapid nucleic acid diagnostics (NAD) technologies have become available to complement or even bypass and replace these traditional microbiological culture and immunological based tests. The main purpose of this review is to describe a number of recently available multiparametric commercial tests, to support the rapid and accurate clinical diagnosis of human gastroenteritis. These state of the art technologies have the ability to identify a wide range of microorganisms associated with enteric gastroenteritis. Following further technological innovation and more comprehensive clinical validation studies, these NAD tests have the potential to impact on the economic burden of health care systems. These rapid NAD tests can also be used to guide improved patient therapy in a timely manner which will reduce the extent of morbidity and mortality associated with these infections globally.

Schlagwörter

Stichwörter der Autor:innen

GastroenteritisIntegrated platformsMultiparametric detectionMultiplex PCR

Autor:innen und Institutionen

  • Nucleic Acid Diagnostics Research Laboratory (NADRL), Microbiology, School of Natural Sciences, National University of Ireland, Galway, Ireland.

Förderung

  • Science Foundation Ireland

Zitieren

APA

Reddington, K., Tuite, N., Minogue, E., & Barry, T. (2014). A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens. Biomolecular Detection and Quantification. https://doi.org/10.1016/j.bdq.2014.07.001

Vancouver

Reddington K, Tuite N, Minogue E, Barry T. A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens. Biomolecular Detection and Quantification. 2014. doi:10.1016/j.bdq.2014.07.001

BibTeX
@article{Reddington2014,
  author = {Reddington, Kate and Tuite, Nina and Minogue, Elizabeth and Barry, Thomas},
  title = {A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens},
  journal = {Biomolecular Detection and Quantification},
  year = {2014},
  doi = {10.1016/j.bdq.2014.07.001}
}
Kostenlos starten →